未来发展控股(01259)计划在金融业务分部内开展保险业务领域的新业务Livzon Pharma (01513): Injection of acetic acid pruline microspheres is newly approved for the indication of "endometriosis"...
Important Matters:
You ji you biology-B (02496) has entered into a licensing and cooperation agreement with CP Group for the dual-specific antibody M701
Prosper Future (01259) plans to launch new insurance business in the financial business segment
Livzon Pharma (01513): Injection of acetic acid pruline microspheres is newly approved for the indication of "endometriosis"
Maoye Int'l (00848): Zibo Commercial Building Co., Ltd. is dissolved due to the expiration of the business term and plans to undergo voluntary dissolution and liquidation
[Financial Data]:
Midea Real Est (03990) recorded a contract sales amount of approximately 28.41 billion yuan in the first 9 months, a decrease of 46.65% year-on-year.
New China Life Insurance (01336) announced a happy profit, with an expected net profit attributable to equity holders for the first three quarters of 18.607 billion yuan to 20.515 billion yuan, a year-on-year increase of 95% to 115%.
Sunac (01918) recorded a contract sales amount of approximately 1.41 billion yuan in September, a decrease of 85.27% year-on-year.
For more details, please refer to the CITIC Securities website ().
